Standard Biotools (LAB) Change in Acquisitions & Divestments (2011 - 2026)

Standard Biotools (LAB) has 15 years of Change in Acquisitions & Divestments data on file, last reported at $15.0 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 71.15% year-over-year to $15.0 million in Q1 2026; TTM through Mar 2026 was $142.0 million, a 50.87% decrease from a year earlier, with the FY2025 full-year figure at $179.0 million, down 48.71% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $15.0 million, down from $25.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for LAB reached as high as $127.0 million in Q2 2024 and fell as low as $12.0 million in Q3 2022.
• Historically, Change in Acquisitions & Divestments has averaged $51.0 million across 5 years, with a median of $49.0 million in 2024.
• Across the five-year window, Change in Acquisitions & Divestments jumped 210.03% in 2024 and slumped 71.15% in 2026, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $41.0 million in 2022, then sank by 36.59% to $26.0 million in 2023, then soared by 130.77% to $60.0 million in 2024, then tumbled by 58.33% to $25.0 million in 2025, then sank by 40.0% to $15.0 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $15.0 million in Q1 2026, $25.0 million in Q4 2025, and $54.0 million in Q3 2025.